Please login to the form below

Not currently logged in
Email:
Password:

Bayer's Kirstyn Nicholas joins Spirit Healthcare

Takes up role as regional business director

edit-Spirit-Healthcare-Kirstyn-NicholasLeicestershire, UK, based Spirit Healthcare has named Kirstyn Nicholas as regional business director.

Nicholas joins from Bayer, where she was principal territory manager for almost ten years.

The role included working with CCG leads, consultants and clinical scientists and prior to that she worked as healthcare development manager at Bayer HealthCare.

Commenting on her appointment, Nicholas said: “I am thrilled to be working for such a refreshingly innovative company that provides a range of high quality products and solution as well as the internal knowledge, passion and commitment to improve patient lives.”

Nicholas has previously specialised in the provision of medical devices designed to help manage screening, symptoms and treatment.

Chris Barker, chief executive of Spirit Healthcare, added: “Kirstyn has only been with the company a few weeks and has already made a significant contribution. It is great to have such talent on the team as we continue to expand.”

The expansion follows the successful launch of EMPOWER Structured Diabetes Education and the introduction of TEE2 to its diabetes portfolio.

Spirit Healthcare is a provider of healthcare solution to the NHS and private hospitals, recently winning a PMEA award for Excellence in Healthcare Collaboration and Partnerships Leicester City TotalCare Project.

11th February 2015

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics